J Clin Med Res. 2018 Mar;10(3):196-201. doi: 10.14740/jocmr3279w. Epub 2018 Jan 26.
Haptoglobin Phenotype Among Arab Patients With Mental Disorders.
Journal of clinical medicine research
Zaher Armaly, Kamal Farhat, Safa Kinaneh, Joseph Farah
Affiliations
Affiliations
- Department of Nephrology, Nazareth Hospital-EMMS, Nazareth and the Galilee Faculty of Medicine-Bar Ilan University, Zafed, Israel.
- Department of Psychiatric, Nazareth Hospital-EMMS, Nazareth and the Galilee Faculty of Medicine-Bar Ilan University, Zafed, Israel.
PMID: 29416577
PMCID: PMC5798265 DOI: 10.14740/jocmr3279w
Abstract
BACKGROUND: Depression, schizophrenia and panic disorder are common mental disorders in the community and hospitalized patients. These mental disorders negatively affect life quality and even expectancy of life. Haptoglobin (Hp) phenotype (Hp 1-1, 1-2, or 2-2) is associated with risk for cardiovascular diseases, but its association with psychiatric disorders, a growing concern in the modern society, has not been studied thoroughly. The aim of the study was to examine whether Hp phenotype is associated with common mental disorders such as depression, schizophrenia, and panic disorder.
METHODS: The study included 92 Arab patients with mental disorders, and among them 44 suffered from schizophrenia (mean age 39 ± 1.5 years), 17 from depression (mean age 44.5 ± 3.1 years), 31 from panic disorder (mean age of 44.9 ± 2.7 years), and 206 healthy Arab control subjects with a mean age of 42.6 ± 0.9 years. Beck's depression inventory assessment and Hamilton depression scale were administered for depression and panic disorder diagnosis. Schizophrenia was evaluated with positive and negative affect schedule (Panas) test. All mental disorders were evaluated by clinical review. Blood analysis for Hp phenotype was performed. Diagnosis was made using the Diagnostic and Statistical Manual of Mental Disorders axis to correlate depression with Hp phenotype.
RESULTS: In mentally healthy controls, 10.7% were Hp 1-1, 38.8% Hp 2-1, and 50.5% Hp 2-2. In patients with the studied psychiatric disorders, Hp phenotype was comparable to healthy subjects; 8.7% were Hp 1-1, 50% Hp 2-1, and 41.3% Hp 2-2. When Hp phenotyping was analyzed in the psychiatric subgroups, Hp 2-1 was more common among depressed and schizophrenic patients, as compared with healthy subjects (58.8% and 52.3% vs. 38.8%). In patients who suffer from panic disorder, Hp phenotype distribution was 6.5% Hp 1-1, 41.9% Hp 2-1, and 51.6% Hp 2-2, suggesting a lower prevalence among Hp 1-1 phenotype.
CONCLUSIONS: Arab patients who carry Hp 2-1 phenotype may be at risk to develop depression or schizophrenia more than the general healthy population. In contrast, Hp 1-1 subjects have a lower prevalence of panic disorder.
Keywords: Association; Depression; Haptoglobin; Mental disorders; Panic disorder; Schizophrenia
Conflict of interest statement
All authors declare that there is no conflict of interest regarding the publication of this paper.
References
- J Am Coll Cardiol. 2002 Dec 4;40(11):1984-90 - PubMed
- JAMA. 2004 Jun 2;291(21):2581-90 - PubMed
- Diabetes. 2008 Oct;57(10):2794-800 - PubMed
- Antioxid Redox Signal. 2010 Feb;12(2):293-304 - PubMed
- Diabetes. 2005 Sep;54(9):2802-6 - PubMed
- Int J Lab Hematol. 2007 Apr;29(2):92-110 - PubMed
- Biochemistry. 2004 Apr 6;43(13):3899-906 - PubMed
- Curr Opin Lipidol. 2015 Oct;26(5):384-7 - PubMed
- Pharmacogenomics. 2010 May;11(5):675-84 - PubMed
- Diabetes Care. 2003 Sep;26(9):2628-31 - PubMed
- Arterioscler Thromb Vasc Biol. 2008 Feb;28(2):341-7 - PubMed
- Lancet Psychiatry. 2016 Feb;3(2):171-8 - PubMed
- Lancet. 2016 Jul 30;388(10043):505-17 - PubMed
- Intern Med. 2015;54(5):453-7 - PubMed
- Amino Acids. 2007 Jan;32(1):101-8 - PubMed
- Epidemiol Psichiatr Soc. 2009 Jan-Mar;18(1):23-33 - PubMed
- Diabetes Care. 2004 Nov;27(11):2767 - PubMed
- Psychiatry Res. 2001 Oct 10;104(1):1-9 - PubMed
- Adv Hum Genet. 1982;12:189-261, 453-4 - PubMed
- Atherosclerosis. 2002 Apr;161(2):441-6 - PubMed
- Diabetes Care. 2013 Oct;36(10):3139-45 - PubMed
- Crit Rev Clin Lab Sci. 2013 Jan-Feb;50(1):1-22 - PubMed
- Metab Brain Dis. 2017 Feb;32(1):19-34 - PubMed
- Diabetes. 2009 Dec;58(12):2904-9 - PubMed
- CNS Spectr. 2016 Apr;21(2):184-98 - PubMed
- Genetika. 1976;12(9):164-5 - PubMed
Publication Types